Bioinformatics analysis and verification of molecular targets in ovarian cancer stem-like cells

Abhijeet Behera1, Rahail Ashraf1, Amit Kumar Srivastava2

  • 1Division of Biology, Indian Institute of Science Education and Research (IISER) Tirupati, Tirupati, Andhra Pradesh, India.

Heliyon
|September 28, 2020
PubMed
Abstract

Insights

This study identifies key genes and pathways in ovarian cancer stem-like cells (CSLCs), crucial for understanding tumor recurrence and chemoresistance. Findings offer potential new therapeutic targets for epithelial ovarian cancer (EOC).

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Epithelial ovarian cancer (EOC) is a lethal malignancy with high relapse rates.
  • Cancer stem-like cells (CSLCs) are implicated in EOC recurrence and chemoresistance.
  • Identifying molecular drivers of CSLCs is critical for novel therapeutic strategies.

Purpose of the Study:

  • To identify the molecular signature and enriched signaling pathways in ovarian CSLCs.
  • To uncover potential therapeutic targets for EOC treatment.

Main Methods:

  • Downloaded and analyzed two Gene Expression Omnibus (GEO) datasets using GEO2R.
  • Identified differentially expressed genes (DEGs) and analyzed their association with overall survival.
  • Performed Gene Ontology (GO), KEGG, Reactome pathway, and protein-protein interaction (PPI) network analyses.
  • Validated key DEGs in SK-OV-3 cells and assessed their role in carboplatin resistance.

Main Results:

  • Identified 200 common DEGs (117 up-regulated, 83 down-regulated) between datasets.
  • Enriched pathways in CSLCs include extracellular matrix, cell proliferation, tissue development, and molecular function regulation.
  • Interferon-alpha/beta signaling, elastic fibers, and bile acid synthesis pathways were significantly enriched in CSLCs.
  • MMP1 and PPFIBP1 expression correlated with overall survival; ADM, CXCR4, LGR5, and PTGS2 expression linked to carboplatin resistance.

Conclusions:

  • Bioinformatics analysis revealed a distinct molecular signature and signaling pathways in ovarian CSLCs.
  • These findings provide a foundation for further research into mechanisms of ovarian CSCs.
  • Identified potential novel therapeutic targets for targeting ovarian CSLCs and overcoming chemoresistance.